Loading...
2 results
Search Results
Now showing 1 - 2 of 2
- Detection of mpox using polymerase chain reaction from the skin and oropharynx over the course of infection: A prospective studyPublication . Correia, Catarina; Alpalhão, M,; de Sousa, D,; Vieitez-Frade, J.; Pelerito, Ana; Cordeiro, Rita; Lopes de Carvalho, Isabel; Núncio, MS; Ferreira, J,; Filipe, P.To the Editor: Since early May 2022, 86,746 mpox virus (MPV) infections have been reported worldwide.1,2 However, its in vivo viral kinetics and infectivity remain unclear.3 We conducted a prospective observational study to determine how long MPV remains detectable in skin lesions and the oropharynx. (...)
- Demographic and Clinical Characteristics of Mpox Patients Attending an STD Clinic in LisbonPublication . Cid Brito, Margarida; Nuncio, M.S.; Lopes de Carvalho, Isabel; Cordeiro, Rita; Pelerito, AnaMpox is a viral disease caused by the monkeypox virus, which marked the year of 2022 with a global outbreak. While previously considered to be a zoonosis of almost exclusive animal-to-human transmission, the current outbreak has been attributed to human-to-human transmission, particularly sexual transmission. As a new sexually transmissible disease, we studied the epidemiological and clinical features, as well as the concomitant occurrence of other sexually transmissible diseases, treatment approach, and outcome of our 291 patients, in the current outbreak. We found a total of 169 concomitant sexually transmissible infections of bacterial and viral origins, corresponding to 107 patients. Neisseria gonorrhoeae was the most common agent, particularly in the anal location. With this work, we emphasize the need for a thorough epidemiological and medical history, as well as a concomitant complete laboratorial screening for other STIs in patients with confirmed or suspected mpox.